The latest edition of the Lung-MAP newsletter is out, with (good news) updates on this precision medicine trial testing targeted new treatments for non-small cell lung cancer.

Despite the COVID-19 pandemic, Lung-MAP is going strong with four sub-studies open for patients and more in the pipeline. Get the details by viewing the newsletter here.

Other Recent Stories

SWOG Front Line banner
Aug 21, 2026
Turning AI to finding clinical trials for patients
Federal and Industry Sponsorship in US Cancer Clinical Trials
Aug 20, 2026
New research details the vital, unique role federal support plays in cancer clinical research
SWOG Front Line banner
Aug 14, 2026
Three studies from our NCORP RB have reported primary results recently